Background It is well known that high total and LDL cholesterol concentrations are not prerequisites for ischemic heart disease. This study aimed to differentiate between patients with coronary heart symptoms and healthy subjects with high cholesterol concentrations, using other potential risk factors such as oxidation state, body iron status and the oxidative state of the LDL particle.
Introduction
Cardiovascular heart disease develops slowly and asymptomatically over many years; however, the ¢rst sign of the disease is often evident at a surprisingly early age. Coronary artery fatty streaks may be present even in the late teens and early twenties, as observed in high proportions of post-mortem investigations of individuals who su¡ered traumatic, non-coronary heart disease deaths. 1, 2 Approximately 30% of coronary heart disease (CHD)-related deaths occurs in individuals with no prior indications of the disease, partially because more than 65% of myocardial infarctions occur in vessels with less than 50% stenosis. 3 This accentuates the importance of the identi¢cation of biochemical markers for the early diagnosis and treatment of CHD.
For many years the most important risk factors for atherosclerosis and CHD were considered to be lipo-protein concentrations. Lipoproteins function mainly as lipid carriers in blood, and over time it became increasingly clear that an elevated total cholesterol concentration was associated with increased risk for CHD. 4, 5 The set point for hypercholesterolaemia was 56.2 mmol/ L, 6 and today a total cholesterol of 5. 26 .2 mmol/ L is regarded as a borderline risk for CHD. 4 Standard risk factors such as cholesterol, LDL, HDL, age, gender, etc. explain only a small percentage of CHD deaths. 7 The discovery of new risk factors and causal pathways continues to challenge our understanding of atherogenesis. Some novel risk factors for atherosclerosis include homocysteine, ¢brinogen, impaired ¢brinolysis, platelet reactivity, hypercoagulability, infections, in£ammation, antioxidants, and oxidation of LDL and body iron. 8 The association of oxidized LDL with atherosclerosis is signi¢cant. Oxidized LDL is present in the arterial wall in atherosclerosis, 9 and many studies have indicated that LDL oxidation is increased in CHD. 6 ,10^12 This is also supported by the presence of oxidized LDL autoantibodies in atherosclerotic lesions and small concentrations of minimally/mildly oxidized LDL in plasma. 13 The chemical events that occur in LDL oxidation are complex; they begin with lipid peroxidation 13 and are characterized by depletion of antioxidants and increased products of protein modi¢cation and lipid peroxidation, resulting in a more electronegative particle. 14 The most important and most abundant antioxidant found in LDL is a-tocopherol, followe d by b-carotene, as well as the potent ubiquinol-10, which is present in relatively low concentrations. 13 Minimally (or mildly) and extensively oxidized LDL can participate in many ways in the atherosclerotic process. 15, 16 Measurement of LDL oxidation, LDL antioxidants and plasma antioxidants therefore seem to be of importance and might distinguish between patients with CHD and healthy persons with a raised cholesterol concentration but without CHD.
Iron can also contribute to atherosclerosis or myocardial ischemia. It seems to be involved in LDL oxidation by virtue of its ability to catalyse the production of highly toxic radicals and the chain reaction of lipid peroxidation. 6, 17 Iron also promotes smooth muscle proliferation, a key step in atherosclerotic lesion progression, and may indirectly increase the susceptibility of LDL to oxidation by reducing the concentrations of antioxidants in plasma. 18 Furthermore, iron promotes atherogenesis by a¡ecting blood lipid concentrations. 19 The aim of this study was to di¡erentiate between patients with symptoms of CHD and healthy persons with a normal or an increased cholesterol concentration by determining other potential risk factors, such as plasma oxidation state (ascorbic acid, a-tocopherol and retinol), body iron content (ferritin, transferrin, transferrin saturation and serum iron) and the composition of the LDL particle (LDL oxidation potential and LDL antioxidants such as retinol and a-tocopherol).
Methods

Patients and controls
A group of 141 apparently healthy volunteers were subdivided into low cholesterol concentration (56 mmol/ L) (LC) and high cholesterol concentration (56 mmol/ L) (HC) groups. An additional group of 40 patients attending the local lipid clinic was included. These patients had symptoms of coronary artery disease. None of these patients used HMG CoA inhibitors (see Table 1 ). Patients with a triglyceride concentration 42.5 mmol/ L were excluded from this study.
The Human Ethics Committee of the University of the Orange Free State granted ethical approval. The investigation conformed to the principles outlined in the Declaration of Helsinki.
Laboratory analysis
Total cholesterol, HDL cholesterol and triglycerides were measured on a Technicon DAX system (Technicon omnipack, product numbers T01 1684, 543 004 and T01-1863 AO, respectively; Bayer Diagnostics, Isando, South Africa).
The LDL cholesterol fraction was isolated from the plasma by a modi¢ed density gradient, short-run, ultra-centrifugation method. 20 Plasma density was adjusted to 1.21g/mL by adding 1.3 mL plasma to 0.37 g KBr in a quick-seal polyallomer ultracentrifuge tube (16£45 mm). This solution was carefully overlaid with 3.5 mL 0.9% saline, pH 7.4, and centrifuged for 2 h at 80 000 g. After ultracentrifugation the LDL cholesterol fraction (+1mL) was aspirated and removed by piercing the side of the tube with a syringe. The LDL cholesterol fraction was desalted by passing the sample through a phosphate-bu¡ered saline (PBS), pH 7.4-bu¡ered Sephadex column (18 mm£90 mm; G-25 medium; 137 mmol/ L NaCl, 2.7 mmol/ L KCl, 1.8 mmol/ L CaCl 2 .2H 2 O 2 , 0.45 mmol/ L MgCl 2 .6H 2 O, 1.0 mmol/ L KH 2 PO 4 and 1.7 mmol/ L K 2 HPO 4 ).
Plasma antioxidants (a-tocopherol, retinol and ascorbic acid) and LDL antioxidants (a-tocopherol and retinol) were analysed with high-pressure liquid chromatography (HPLC) as described previously 21 [percentage coe¤cient of variation (%CV) withinbatch: ascorbic acid, 1.04; a-tocopherol, 0.22; retinol, 0.14. %CV between-batch: ascorbic acid, 1.76; atocopherol, 0.7; retinol, 2.2].
Low-density lipoprotein oxidative potential was determined on the isolated LDL cholesterol fraction. Cholesterol was adjusted to 80 mg/mL with PBS, pH 7.4, and oxidation induced by the addition of 10 mmol/L CuSO 4 . Conjugated diene production was measured by monitoring absorbance (258C) at 234 nm at 2-min intervals for 6 h. Results are expressed in minutes (LDL oxidative potential or lag time), de¢ned as the time required to overcome the inherent ability of LDL to resist oxidation 20 (%CV: within-batch, 1.6; between-batch, 1.7). Lipid hydroperoxide concentration was measured on the isolated LDL cholesterol fraction by the method of Jiang et al. 22 (%CV: within-batch, 4.5; betweenbatch, 4.6).
The ferritin assay was based on microparticle enzyme immuno -assay (MEIA) technology (Abbott Diagnostics, IMX in-vitro test number 2219-20, Johannesburg, South Africa).
Transferrin was measured using a routine nephelometric method with Dade Behring kit OSAX 15 (Ranjesfontein, South Africa).
Serum iron was measured with a Technicon radioimmunoassay system, using a serum iron kit (product number T01 1583-01, Bayer Diagnostics).
Transferrin saturation was calculated from serum iron and transferrin concentrations. 23
Statistical analysis
Descriptive statistics, namely the mean, minimum and maximum, were calculated. Groups were compared with one another using the Student's t-test, and P50.05 was considered as statistical signi¢cance.
Results
The total and LDL cholesterol concentrations of the LC group were signi¢cantly less than those of the HC and patient groups. Both total and LDL cholesterol concentrations were less in the patient group than in the HC group. The HDL cholesterol concentrations of the three groups were similar. The triglyceride concentration of the LC group was signi¢cantly less than that of the HC group, but no di¡erence was observed for this parameter between the HC and patient groups (see Table 2 ).
The plasma ascorbic acid concentration (see Table 3 ) was lower in the HC group than in the LC and P groups. a-Tocopherol concentration did not di¡er signi¢cantly between the three groups. Retinol concentration was higher in the LC group, but there was not a statistically signi¢cant di¡erence in this parameter between the HC and P groups.
No di¡erences existed between the LC and HC groups for any of the parameters measured on the isolated LDL particles (see Table 4 ). However, the following parameters di¡ered signi¢cantly in the P group compared with the other two groups: LDL oxidative potential (less) and LDL a-tocopherol concentration (less). Only 3.5% of the LC and the HC groups had an LDL oxidative potential less than 93.5 min (average of patients), compared with 46% in the P group. Similar results were observed in the LDL a-tocopherol concentration: the LC, HC and P groups had values of 18%, 19% and 62% lower than 11.73 mmol/mmol cholesterol, respectively (average of patients). Lipid hydroperoxide and retinol concentrations were similar. Ferritin concentration was greater in the P than the LC group, but no di¡erences occurred in the LC compared with the HC group or in the HC compared with the P group (see Table 5 ). None of the other body iron parameters (transferrin concentration, transferrin saturation and serum iron concentration) showed any statistically signi¢cant di¡erences.
Discussion
It is well known that increased total and LDL cholesterol concentrations are not prerequisites for ischemic heart disease. The aim of this study was to di¡erentiate between patients with symptoms of heart disease and healthy persons with a high cholesterol concentration. Total cholesterol, LDL, HDL cholesterol and triglyceride concentrations were not increased in the P group compared with the HC group. This, together with the HDL cholesterol concentration, which was similar in all three groups, made it impossible to discriminate between these two groups (see Table 2 ) using the lipoprotein parameters.
Although it seemed that ferritin concentration was greater in the P than in the LC group, no di¡erence was observed between the HC and P groups. Routine parameters of body iron content, therefore, could discriminate between CHD patients and persons with increased cholesterol concentration (see Table 5 ). Low molecular weight iron, or non-transferrin bound iron, constitutes a pool of intracellular iron chelates which is responsible for the intracellular iron transfer. This pool is important as it acts as a catalyst in free radical reactions. 24 This should be assessed before iron can be ruled out as having a role in atherosclerosis. The function of antioxidants in inactivating radical species is well known. Some authors have suggested a decreased antioxidant concentration as a risk factor for atherosclerosis and CHD, 25,26 especially a-tocopherol, while others have been unable to do so. 27^30 It was impossible to distinguish between the HC and P groups by plasma antioxidant concentration; no signi¢cant di¡erences occurred (see Table 3 ). Only plasma ascorbic acid concentration was reduced in the HC group compared with the LC and P groups. Although a-tocopherol is frequently assessed as a measure of low antioxidant concentration, 26,31^33 no di¡erences in this parameter were found between the three groups.
Extensive modi¢cation of LDL takes place only in the arterial intima, but it is possible that LDL circulating in the bloodstream is already mildly modi¢ed, which may enhance modi¢cation in the arterial intima. Evidence exists for mildly oxidiz ed LDL in circulating plasma, although this fraction is very small. The pool may have a rapid turnover, which, over time, would mean production of large quantities within the circulation. 34 Minimally and extensively oxidiz ed LDL have striking biological activities in the atherosclerotic process, including (among many others): unregulated uptake by macrophages and induction of foam cell formation; chemotactic monocyte attraction; and increased adhesion of monocytes to endothelial cells. 16 At the same level of plasma LDL concentration, it is evident that considerable variation exists within the general population in susceptibility of LDL to oxidative modi¢cation. Di¡erences in in£ammatory and immunological reactions caused by o-LDL may also partially explain the di¡ering susceptibility to atherosclerosis between individuals. 35 In this study we used two di¡erent assays for the measurement of LDL oxidation, namely LDL oxidative potential and the antioxidant content of isolated LDL. The LDL oxidative potential was signi¢cantly less in the P group compared with the LC and HC groups (see Table 4 ), indicative of oxidized LDL.
Further evaluation of LDL by measuring a-tocopherol and retinol content was signi¢cant, as the amount of antioxidants predict the protection of the LDL particle against oxidation. 13 The exact concentration of a-tocopherol in LDL is, however, highly debatable. Some authors have reported that a-tocopherol is evenly distributed between HDL and LDL, with the content determined by the relative abundance of cholesterol and phospholipid s in the particle. 36 Others have indicated that the a-tocopherol content is independently associated with lipid core size. 37 a-Tocopherol is the most abundant lipid-soluble antioxidant in humans, and it concentrates in the LDL particles as well as in the arterial wall. 38 Our results indicated that the a-tocopherol concentration was increased in LDL (see Table 4 ). In contrast to other authors, 39 we were not able to ¢nd an association between plasma and LDL a-tocopherol concentrations in healthy persons (rˆ0.05; Pˆ0.67) or in CHD patients (rˆ70.04; Pˆ0.79), supporting the ¢ndings of Halevy et al. 10 The concentration of LDL a-tocopherol was less in the P group compared with the LC and HC groups (see Table 4 ). Plasma a-tocopherol concentration was therefore unable to distinguish between the HC and P groups, but LDL oxidative potential and LDL a-tocopherol concentration could do so. These results suggest LDL oxidation. The LDL retinol concentration and LDL lipid peroxidation were unable to distinguish between the HC and P groups. These results indicate that the oxidative state of LDL discriminated between the HC and P groups.
Despite the occurrence of both a reduced LDL atocopherol concentration and a reduced LDL oxidative potential in the P group (see Table 4 ), these two parameters showed no correlation with each other in healthy persons or CHD patients (rˆ0.188, Pˆ0.21 and rˆ0. 20, Pˆ0.19, respectively) . Although other factors can also in£uence the LDL oxidative potential (e.g. particle size and fatty acid composition), several studies have showed that LDL oxidative potential is a¡ected by the a-tocopherol content of LDL. 13, 33 The absence of a correlation between LDL oxidative potential and LDL a-tocopherol content in this study might be signi¢cant. Plasma a-tocopherol concentrations in the P and the HC groups were the same, suggesting that the distribution of a-tocopherol might be di¡erent in patients or that other, unmeasured antioxidants may play a major role.
a-Tocopherol has a bene¢cial e¡ect on CHD in various ways, including down-regulation of cellular adhesion molecule (VCAM) expression, 40 signal transduction, 41 inhibition of platelet activation, 42 and prevention of oxidation of endothelium and LDL. 39, 43 However, a signi¢cant number of a-tocopherol supplementation studies have yielded negative results. 10, 38, 44, 45 The CHD patients' LDL was oxidized but that of the HC group was not. According to the above statement, patients could bene¢t from additional antioxidant. It was interesting that fewer patients took vitamin supplementation (15%), compared with the LC (23%) and the HC (26%) groups. Most studies have measured a-tocopherol in the plasma and not in the LDL. Our results indicate the importance of the LDL a-tocopherol concentration to discriminate between the HC and P groups.
Oxidized LDL has a large range of biological e¡ects 16 that can contribute to the atherosclerotic process, but a-tocopherol also has many biological e¡ects 39^43 that prevent atherosclerosis. Perhaps it is important to distinguish between the e¡ect of oxidiz ed LDL and the e¡ect of a de¢ciency of LDL a-tocopherol and to draw correlations between these two. As LDL, and, more speci¢cally, oxidized LDL, plays such a large role in atherosclerosis, it is important to measure the a-tocopherol content of this particle, as it is an abundant antioxidant in LDL. It would also be valuable to know what exactly determines the distribution of a-tocopherol between the lipoprotein particles, as our results indicate that although the LDL a-tocopherol concentration decreased in CHD patients, the plasma a-tocopherol concentration was not reduced.
Conclusion
Our results indicate that total, LDL and HDL cholesterol concentrations, body iron parameters and plasma antioxidant concentrations did not di¡er between healthy, hypercholesterolaemic subjects and patients with CHD. The LDL oxidative potential and LDL a-tocopherol concentration were drastically reduced in the patient group compared with the hypercholesterolaemia group, indicating that the composition of the LDL particle can discriminate between normal, hypercholesterolaemic subjects and CHD patients.
